Clinical Nutrition For Diabetes Care Market Size, Share & Trends Analysis Report By Product (Oral, Enteral Feeding Formulas, Parenteral Nutrition), By Stage, By Sales Channel, And Segment Forecasts, 2024 - 2030

Market Size & Trends

The global clinical nutrition for diabetes care market size was estimated at USD 2.15 billion in 2023 and is expected to register a CAGR of 4.78% from 2024 to 2030. The increasing demand for specialized food products by individuals with diabetes or those at risk of developing the condition is a critical factor for the diabetes clinical nutrition market growth. This includes people with type 1 or type 2 diabetes, as well as those following a diabetic diet. According to the International Diabetes Federation, Europe had 61 million diabetes patients in 2021, accounting for 10.3% of men and 9.6% of women aged 25 years and over. Moreover, by 2045, 1 in 8 adults, approximately 783 million, will be living with diabetes, depicting a 46% rise from the current statistics. Moreover, over 90% of people with diabetes have type 2 diabetes, which is driven by socio-economic, demographic, environmental, and genetic factors.

The increase in the prevalence of diabetes due to aging, obesity, and unhealthy lifestyle is one of the factors contributing to the growth of the global clinical nutrition market. Obesity is a major factor leading to diabetes. According to the World Health Organization (WHO), in 2021, an estimated 39% of adults aged 18 years and over were overweight, and 13% were obese globally. According to an article published in ScienceDirect in July 2021, the prevalence of peripheral neuropathy was high among diabetic patients, accounting for around 40.3%, and type 2 diabetic patients are more susceptible to it than type 1 diabetic patients. The risk of neuropathy significantly increases with age, changes in diet, and unhealthy lifestyles. Clinical nutrition including medical foods and parenteral nutrition can help relieve symptoms or slow down the progression of a chronic condition.

A study by the University of Minnesota suggests that the incidence of type 2 diabetes increased by 62% in the U.S., following the coronavirus outbreak. Moreover, kids aged 10-19 were among those specifically affected. The COVID-19 pandemic catalyzed the shift towards different care models and paving the way for the swift introduction of novel solutions for diabetes management. As the number of people with diabetes continues to grow, so does the demand for these specialized food products. Patients afflicted with diabetes are at higher risk of comorbidities, as diabetes is a major cause of blindness, kidney failure, heart attacks, stroke and lower limb amputation, as reported by the WHO.

The increasing popularity of diabetes nutrition food is driven by a combination of scientific evidence, public health initiatives, and consumer demand for better health outcomes. Consumer behavior regarding diabetic care nutrition focuses on prioritizing low-sugar, low-carbohydrate, and low-calorie foods while maintaining palatability and ease of preparation. Moreover, their preference for healthier alternatives is driven by a combination of personal health concerns, taste preferences, convenience, and budget considerations. Many consumers are willing to spend more for products that are perceived as healthier, indicating a strong desire to make informed decisions about their dietary habits.

Market Concentration & Characteristics

The market growth is moderate, and the pace of market growth is accelerating. The global clinical nutrition market for diabetes care is characterized by a moderately high degree of innovation. The market is dominated by a few large global companies accounting for the majority market share. Advancements in enteral nutrition have led to the creation of diabetes-specific enteral formulas (DSF) with higher fat contents, particularly medium-chain triglycerides and monounsaturated fatty acids, and increased fiber, resulting in improved glycemic control and reduced insulinemic response.

Companies in the clinical nutrition for diabetes care market are involved in strategic initiatives such as mergers, collaboration, agreements, and acquisitions to expand the nutrition portfolio, propelling market growth globally. For instance, in May 2022, Nestle Health Science agreed to acquire Puravida to expand the NHSc portfolio of nutrition segment in Brazil.

The regulatory framework in clinical nutrition prescribed for diabetes care is in accordance with regulations for dietary management globally. Medical food’s exemption from FDA’s regulation for nutrient content and health claims is a factor contributing to market growth.The FDA encourages the adoption of enteral device connectors to reduce the risk of patient injury and misconnection. Thus, effective reimbursement policies and regulatory guidelines, especially in home-based healthcare, are expected to boost the adoption of clinical nutrition such as diabetes care foods.

Products such as the Glucagon Emergency Kit launched by Fresenius Kabi in the U.S. (2020) to treat sudden hypoglycemic episodes in diabetic patients are good examples of product innovation in the market. Moreover, the integration of telemedicine and remote monitoring systems is facilitating self-management of diabetes and ensuring adherence to proper nutrition plans. Mobile applications and wearable devices are being implemented to track dietary intake, blood glucose levels, and physical activity patterns, providing real-time feedback and personalized coaching. Fresenius Kabi’s KabiCare is a prominent example of such platforms.

The prevalence of diabetes is significantly rising in China, contributing to the expansion of the clinical nutrition market in Asia Pacific. Accordingly, the market is witnessing regional expansion of major market players, owing to the increasing demand for clinical nutrition for metabolic disorders such as diabetes care.

Product Insights

Oral clinical nutrition for diabetes care dominated the market in 2023, commanding a 71% market share. Oral nutritional therapy is vital for diabetes management as it significantly aids in controlling blood sugar levels, supports weight regulation, and helps avoid diabetes-related complications. There is substantial evidence indicating that oral nutrition therapy is both effective and cost-efficient when integrated into a holistic approach to diabetes care.

Enteral feeding formulas in diabetes care are expected to grow at the fastest pace over the forecast period. The demand for diabetes-specific enteral feeding formulas is on the rise, driven by numerous studies that attest to their efficacy in managing diabetes patients who need enteral nutrition. When compared to standard formulas, DSFs have shown superior performance in regulating HbA1c and insulin response in diabetes patients on enteral feed. Therefore, the adoption of diabetes-specific enteral feeding formulas presents benefits in terms of blood sugar control and comprehensive care for diabetes patients who require enteral nutrition.

Stage Insights

Adults segment led the diabetes clinical nutrition market with a share of over 85% in 2023, owing to the increasing prevalence of nutritional deficiency and malnutrition among the adult population. Adult age group are more prone to the reduced muscle strength, vitamins, and calcium deficiency among the women population of age group above 30 years, apathy, lower immunity, hypertension, and fatigue. This leads to the nutritional deficiency among the adult population. According to the OECD, India, Sri Lanka, Pakistan, and Bangladesh are prominent contributors to the global burden.

The adults segment is also anticipated to grow the fastest over the forecast period. Globally, the total cases of diabetes in adults has seen a rise due to growing urbanization, sedentary lifestyles, and unhealthy eating habits. Physical inactivity is a popular trend seen in the adult population and contributes to poor blood sugar control, weight gain, and insulin resistance. The rise in geriatric population is also a major factor contributing to segment growth.

Sales Channel Insights

The institutional sales segment dominated the market with over 40% revenue share in 2023. The sales channel includes commercial sales to the government organizations, hospitals, and research institutes. The rising prevalence of the diseases and advancements in the hospital care leads to the rise in the patient visits to the hospitals which drives the segment. Moreover, as patient awareness rises, the tendency to use official hospital channels for obtaining diabetes care nutrition prescriptions has also seen a growth.

The online sales segment is anticipated to witness fastest growth over the forecast period. The progress in telemedicine and ePharmacy has facilitated global distribution of clinical nutrition products, enabling manufacturers to expand their reach and cater to underrepresented communities. Hence, there is an increase in the online sales due to the rising customer demand for diabetes care supplements via online platforms and stores.

Regional Insights

North America clinical nutrition for diabetes care market accounted for a share of 33.28% in 2023. The large market share in the region is driven by a strong healthcare infrastructure, favorable reimbursement policies and the presence of large clinical nutrition companies. Moreover, high public and private investment in healthcare and a shift towards wholistic treatment regimens has aided the market growth in the region.

U.S. Clinical Nutrition for Diabetes Care Market Trends

The U.S. clinical nutrition market for diabetes care dominated the North American region with approximately 87% revenue share. The market for clinical nutrition for diabetes care is expanding swiftly worldwide; however, the U.S. leads the way due to its robust healthcare system and an increasing elderly population. The country is at the forefront of technological developments, specifically in healthcare.

Europe Clinical Nutrition for Diabetes Care Market Trends

Clinical nutrition for diabetes care market in Europe was the second-largest regional market in 2023. European guidelines by the Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD), backed by scientific evidence to manage diabetes, stress the significance of eating plant-based foods that are minimally processed. By following evidence-based dietary recommendations and receiving individualized medical nutrition therapy (MNT), individuals with diabetes in Europe can effectively manage their condition, reduce complications, and improve their overall quality of life.

Germany clinical nutrition for diabetes care market dominated Europe a share of over 19% in 2023 and is anticipated to witness lucrative growth over the forecast period. Healthcare facilities in Germany are known for their high-quality treatment of complications related to diabetes. They prioritize conservative treatments as much as possible and only opt for surgical procedures such as organ transplants when absolutely necessary. Furthermore, they utilize advanced diagnostic techniques and usage of personalized nutrition, which allow for the early identification and management of complications associated with diabetes, thereby improving the prognosis for patients.

Clinical nutrition for diabetes care market in UK is the second largest in Europe, and is anticipated to witness lucrative growth. In the UK, a range of diabetes medications are available, including metformin, sulphonylureas, DPP-4 inhibitors, SGLT2 inhibitors, and GLP-1 receptor agonists. These drugs are effective in controlling blood glucose levels and averting complications. The goal of these medications is to ward off immediate complications such as hypoglycemia and hyperglycemia, while also minimizing the risk of chronic complications like cardiovascular diseases and kidney problems. These medications in combination of medical food are effective in the management of diabetes. In England, type 2 diabetes patients are exempt from paying for their medications, promoting adherence to their prescribed treatment plans due to the availability of free prescriptions. Such favorable government initiatives will further boost the country's market growth.

Asia Pacific Clinical Nutrition for Diabetes Care Market Trends

Clinical nutrition for diabetes care market in Asia Pacific is anticipated to witness lucrative CAGR of nearly 6% from 2024 to 2030. According to PubMed, the high incidence of diabetes in the Asia-Pacific region is a major issue, as over 60% of individuals with diabetes live in Asia, especially in nations such as China and India. With the rising prevalence of diabetes in the Asia-Pacific region, there is a growing recognition of the importance of implementing effective strategies to address these challenges including the effective nutritional management of patients suffering from diabetes.

China clinical nutrition for diabetes care market recorded the largest revenue share of over 32% in Asia pacific in 2023 and is expected to grow at a lucrative CAGR over the forecast period. In China, the usage of prescribed clinical nutrition varies depending on specific conditions and settings. The implementation of clinical nutrition in China is expanding, especially in the context of addressing malnutrition among the elderly. The country also implemented a National Nutritional Plan aimed towards educating the importance of dietary management from 2017 to 2030.

Clinical nutrition for diabetes care market in India is anticipated to witness the fastest growth during the forecast period. Clinical nutrition is essential in India, aiding the adoption of diets with proper glycemic control and lipid profiles. Baxter International Inc., a global leader in clinical nutrition, has led initiatives to raise awareness about the proper nutrition for diabetes in India. Furthermore, in August 2022, Bayer launched a pill to manage chronic kidney disease associated with diabetes type 2.

Japan clinical nutrition market for diabetes care is a significant part of the Asia Pacific region and is expected to see lucrative growth during the forecast period. The consensus statement on ‘Pharmacotherapy in People with Type 2 Diabetes Mellitus’ by the Japan Diabetes Society emphasizes the need to take into account factors such as the patient’s metabolic imbalance, age, obesity, insulin secretion/insulin resistance, and chronic complications when choosing antidiabetic drugs and clinical nutrition formulas.

Key Clinical Nutrition for Diabetes Care Company Insights

The clinical nutrition market for diabetes market is concentrated with prominent companies accounting for a large percentage. Companies in the diabetes clinical nutrition market are collaborating with regional players and expanding globally to expand their services and product portfolios. Some of the key clinical nutrition for diabetes care companies operating in the global market include Abbott Laboratories; Nestlé S.A.; Danone S.A.; Fresenius Kabi AG; and Mead Johnson & Company, LLC.

Global clinical nutrition for diabetes care market companies have resorted to varied strategic initiatives for sustained growth, such as mergers, collaborations, product development, and global and regional expansion. For instance, global players in the market are collaborating with local distributors and sales channels to expand their reach.

Recent Developments

• In June 2023, Fresenius Kabi announced the launch of the Vasopressin Injection, USP, a generic equivalent to their Vasostrict, which helps adults with vasodilatory shock. According to the company, patients may experience reversible diabetes insipidus after cessation of treatment with vasopressin.

• In April 2022, Abbott’s Q1 Reports suggested that Glucerna, a leading diabetes nutrition brand, achieved global sales growth of 1.2% on a reported basis and 5.2% organically.

• In December 2021, Danone India has introduced Protinex Diabetes Care, which caters to the nutritional needs of individuals in India who have diabetes. This product is scientifically formulated to provide sufficient amounts of protein and fiber essential in regulating blood sugar levels.

• In December 2021, Nestle Health Science launched its first prediabetes program in Malaysia comprising a novel food supplement which can be sprinkled over meals as part of a healthy diet to help maintain normal blood glucose after a meal.

Clinical Nutrition For Diabetes Care Market Report Scope

Global Clinical Nutrition For Diabetes Care Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global clinical nutrition for diabetes care market report based on product, stage, sales channel, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Oral Nutrition

  • Parenteral Nutrition

  • Enteral Feeding Formulas

• Stage Outlook (Revenue, USD Million, 2018 - 2030)

  • Adult

  • Pediatric

• Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)

  • Online

  • Retail

  • Institutional Sales

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait